1140P Cemiplimab versus historical systemic treatments for locally advanced (la) or metastatic (m) cutaneous squamous cell carcinomas (CSCC): Results from the French study TOSCAE. Gérard, Caroline Robert, Émilie Lanoy et al.|Annals of Oncology|2023Cited by 5